For patients with cancer cachexia new mechanism-based pharmacological interventions are required, in addition to a standardized palliative cancer care and basic cachexia management approach. The melanocortin system is one of the important targets for...

Klinische Forschung - 10.11.2010 - 31.12.2011

Abgebrochen

Projektleitung: Jörger Markus, Strasser Florian
Mitarbeiter/innen: Haile Sarah, Hundsberger Tom